"To be used in the event of a terrorist attack," said Dr. Martin Hauer-Jensen a doctor Pharmaceutical Science in the Division of Radiation Health.
He's developing the medication, along with a team of about 20.
"It's a drug that protects guts from radiation," he said.
It's meant to protect intestines and vital organs during a biochemical terrorist attack.
This team has been given $8.7 million more after an initial $4.7 million for their work.
"It's the largest grant to College of Pharmacy in its 60 year history," said Dr. Hauer-Jensen.
While the drug is being developed to combat terrorism, it also has a second function.
"I hope it benefits them and makes cancer treatment safer and more effective," he said.
It's also helping cancer patients who are going through radiation treatments.